COQ8A-ataxia is a mitochondrial disease in which a defect in coenzyme Q10 synthesis leads to dysfunction of the respiratory chain. The disease is usually present as childhood-onset progressive ataxia with developmental regression and cerebellar atrophy. However, due to variable phenotype, it may be hard to distinguish from other mitochondrial diseases and a wide spectrum of childhood-onset cerebellar ataxia. COQ8A-ataxia is a potentially treatable condition with the supplementation of coenzyme Q10 as a main therapy; however, even 50% may not respond to the treatment. In this study we review the clinical manifestation and management of COQ8A-ataxia, focusing on current knowledge of coenzyme Q10 supplementation and approach to further therapies. Moreover, the case of a 22-month-old girl with cerebellar ataxia and developmental regression will be presented.
CITATION STYLE
Paprocka, J., Nowak, M., Chuchra, P., & Śmigiel, R. (2022, October 1). COQ8A-Ataxia as a Manifestation of Primary Coenzyme Q Deficiency. Metabolites. MDPI. https://doi.org/10.3390/metabo12100955
Mendeley helps you to discover research relevant for your work.